德希尼布福默詩 FTI 深 滬
等待開盤 03-26 09:30:00 美东时间
70.77
+0.610
+0.87%
華盛通- 最 高71.4875
- 今 開70.36
- 成交量 334.80万股
- 最 低 69.74
- 昨 收 70.16
- 總市值 283.11亿
- 52周最高 71.4875
- 市盈率 靜 30.82
- 換手率 0.84%
- 52周最低 21.915
- 委 比 -97.97%
- 總股本 4.00亿
- 歷史最高 71.4875
- 量 比 0.57
- 振 幅 2.49%
- 歷史最低 0.9014
- 每 手 1
- 風險率 11.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 最高240美元，潜在涨幅53%！ARM获多家大行上调目标价；Braze 评级上演 “两极反转”，小摩、巴克莱上调，高盛、花旗下调
今日重点评级关注：HC Wainwright & Co.：维持OCUGEN"买入"评级，目标价从7美元升至10美元；HC Wainwright & Co.：维持Maze Therapeutics"买入"评级，目标价从60美元升至110美元
今天 11:41
Susquehanna Maintains Positive on TechnipFMC, Raises Price Target to $82
Susquehanna analyst Charles Minervino maintains TechnipFMC (NYSE:FTI) with a Positive and raises the price target from $71 to $82.
今天 01:32
Shares of oil-related companies are trading higher amid continued military strikes targeting energy infrastructure across the Middle East.
Shares of oil-related companies are trading higher amid continued military stri...
03-20 02:09
Shares of oil services-related companies are trading lower after Middle East tensions led peer SLB to lower its Q1 sales guidance, demobilize staff in several Gulf countries and increase its cost assumptions.
Shares of oil services-related companies are trading lower after Middle East te...
03-13 01:21
美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
Goldman Sachs Maintains Buy on TechnipFMC, Raises Price Target to $66
Goldman Sachs analyst Ati Modak maintains TechnipFMC (NYSE:FTI) with a Buy and raises the price target from $55 to $66.
03-05 00:12
Top 10 Energy Stocks of February: Who Outperformed the Market?
As we move into the third month of 2026 amidst tense geopolitical conditions, below is a list of the best performing 10 energy stocks with market capitalizations of $10 billion or more in the month of...
03-02 22:35
美股大行评级 | 最高300美元！大摩、小摩、花旗纷纷上调英伟达目标价；赛富时、C3.ai、Snowflake、Trade Desk等遭数十家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从47美元升至49美元；Citizens：维持Ironwood医药"跑赢大市"评级，目标价从8美元升至10美元
02-27 11:07
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
